Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The description goes well beyond the readOnly/idempotent annotations by disclosing fallback behavior (LEI/FIGI enrichment degrades gracefully, EDGAR identifiers still return), source labeling, explicit treatment of unresolvable identifiers under `unresolved`, and internal cascading through multiple endpoints. It also explains how ISINs are mapped to legal entities. This gives an agent an accurate mental model of what happens under success and partial-failure conditions.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but every section carries decision-relevant information: examples, supported types, input constraints, fallback behavior, and endpoint cascading. It is front-loaded with the core purpose and the "Use FIRST" guidance before diving into detail. The heavy use of nested parentheticals makes it dense to parse, but not bloated relative to the tool's complexity.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries the full burden of explaining return fields, and it does: CIK, ticker, company_name, LEI, FIGI, RxCUI, ingredient, brand, citation, and `unresolved`. It also covers edge cases like non-equity instruments, non-US issuers, ISIN input, and brand/generic drug names. For a two-parameter lookup tool with rich behavior, nothing critical is missing.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Even though schema coverage is 100%, the description adds critical meaning beyond the parameter schema. For `value`, it explicitly warns to pass the entity name only, never the question's full noun phrase, and gives a concrete example with "NEW YORK ST DORM AUTH" versus the invalid "NEW YORK ST DORM AUTH revenue bonds." It also explains what each `type` accepts and returns, which materially improves invocation correctness.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description names the exact job — resolving a user-spoken name to canonical identifiers that other tools require — and is packed with concrete example queries. The instruction "Use FIRST whenever you have a name but need an ID" clearly separates it from sibling tools that consume already-resolved IDs. It is specific, actionable, and not merely a restatement of the title.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly states when to use the tool: "Use FIRST whenever you have a name but need an ID." It also explains that it replaces 2-3 manual lookups, which frames it as a preliminary step before other tools. It does not name sibling tools or give explicit when-not-to-use guidance, but the core routing instruction is strong and unambiguous.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.9/5.0
Disambiguation3/5

The toolset is mostly organized by clear subdomains, but there are multiple overlapping entry points: ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, and deep_research all answer research questions and the beta version is currently identical to the stable router. Detailed descriptions reduce confusion, but an agent could still reasonably pick the wrong one for a given task. The entity, memory, and subscription tools are more clearly separated.

Naming Consistency3/5

Names are consistently lower_snake_case and readable, but the set mixes verb-led names (compare_entities, resolve_entity, validate_claim) with noun-led names (entity_profile, polymarket_edges, pipeworx_trending) and some odd pairings like ai_visibility_check vs scan_competitor_ai_presence. No chaotic camelCase or inconsistent separators, but the convention is not uniform enough for a strong score.

Tool Count2/5

34 tools is past the 25+ threshold and the surface spans many unrelated domains: structured data lookup, prediction markets, AI visibility marketing, city open data, npm dependency checking, llms.txt generation, memory, and subscriptions. Each tool may be individually useful, but the collection feels like a platform dump rather than a tightly scoped server. A more focused server would split off prediction markets, AI visibility, and utility tools.

Completeness4/5

The main data-research workflow is well covered: discovery, routing, grounded answering, deep research, entity resolution, profiles, comparisons, recent changes, claim validation, and search-within-results are all present. Prediction-market analysis, memory, and subscription lifecycles also have no major dead ends. Minor gaps exist, such as no write/update path for open data and no subscription option for AI-visibility monitoring, but these are not central to the apparent core purpose.